TGY2IT
ABBV icon

Timothy G. Youngquist 2020 Irrevocable Trust’s AbbVie ABBV Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-624
Closed -$136K – 118
2026
Q1 		$136K Buy
+624
New +$138K 0.06% 138

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's ABBV Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 624 shares — an estimated $136K sold.

Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in ABBV in Q1 2026 and held it in 1 quarter. The position peaked at $136K in Q1 2026. 4,232 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Timothy G. Youngquist 2020 Irrevocable Trust reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust sold 624 AbbVie shares in Q2 2026, an estimated $136K.
  • Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in AbbVie in Q1 2026 and held it in 1 quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust's AbbVie position peaked at $136K in Q1 2026.
  • 4,232 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.